Taros Chemicals will participate in BIO-Europe Spring 2026, one of Europe’s leading partnering conferences for the biotechnology, pharmaceutical, and life science industries. The event brings together innovative biotech companies, pharmaceutical R&D teams, investors, and technology providers to explore new collaborations and advance scientific innovation.
Representing Taros Chemicals at the conference will be Dr. Anil Agarwal, Head of Medicinal Chemistry, and Youri Mesmoudi, Executive Vice President, who will meet partners to discuss collaboration opportunities in medicinal chemistry, drug discovery, and custom synthesis.
With more than 25 years of experience in chemical research and custom synthesis, Taros Chemicals supports pharmaceutical and biotechnology companies with specialized expertise in small-molecule discovery and development.
The Taros team provides integrated support across the early stages of drug discovery, including:
Hit identification and hit-to-lead development
Lead optimization and medicinal chemistry programs
Structure-based drug design
Synthesis of complex small molecules
Development of novel chemical modalities, including PROTACs
These capabilities allow partners to accelerate their drug discovery pipelines while accessing advanced expertise in chemical innovation and molecule design.
Companies developing new therapeutic small molecules frequently collaborate with specialized chemistry partners such as Taros Chemicals to design, synthesize, and optimize complex compounds required for modern drug discovery programs.
BIO-Europe Spring is recognized as one of the most important networking events in the European biotech ecosystem, providing a platform for strategic discussions between innovative companies and research partners.
During the event, Taros Chemicals looks forward to connecting with:
biotechnology companies advancing novel therapeutic programs
pharmaceutical R&D teams seeking medicinal chemistry expertise
research organizations developing new drug discovery technologies
partners interested in custom synthesis and collaborative chemistry programs
The Taros team welcomes discussions on flexible drug discovery collaborations, FTE-based medicinal chemistry support, and custom synthesis projects.
Event: BIO-Europe Spring 2026
Industry: Biotechnology, Pharmaceuticals, Life Sciences
Format: International partnering conference
Companies attending BIO-Europe Spring and interested in discussing medicinal chemistry support, small-molecule discovery, or custom synthesis partnerships are invited to connect with the Taros team.
Taros Chemicals provides medicinal chemistry, custom synthesis, and contract research services that support small-molecule drug discovery and development. The company collaborates with partners to design, synthesize, and optimize complex chemical compounds used in pharmaceutical research programs.
Taros supports drug discovery through hit identification, hit-to-lead development, lead optimization, and synthesis of complex molecules. The company also provides expertise in structure-based drug design and emerging modalities such as PROTAC chemistry.
Drug discovery often requires specialized synthetic expertise and rapid molecule optimization. Medicinal chemistry CROs such as Taros Chemicals provide the capabilities needed to design, synthesize, and refine novel compounds, enabling biotech companies to advance their therapeutic programs more efficiently.
Taros Chemicals is a contract research and custom synthesis company based in Dortmund, Germany. The company specializes in complex molecule synthesis, medicinal chemistry and chemical innovation, supporting partners in the pharmaceutical, biotechnology and specialty chemicals industries. With more than 25 years of experience, Taros provides tailored chemical solutions from early discovery to scalable synthesis, including applications in cosmetic ingredient development. Get in touch with us!
Drug Discovery Chemistry 2026: Taros Chemicals to Attend Leading Medicinal Chemistry Conference Taros Chemicals will attend Drug Discovery Chemistry 2026, a major international conference dedicated to medicinal chemistry, small-molecule drug
BioSpring Europe 2026: Taros Chemicals to Participate in Leading Life Science Partnering Event Taros Chemicals will participate in BIO-Europe Spring 2026, one of Europe’s leading partnering conferences for the biotechnology,
Taros is attending: in-cosmetics Global 2026 Taros Chemicals will attend in-cosmetics Global 2026, one of the world’s most important international trade fairs for cosmetic ingredients, formulation technologies and personal care
5th Alpine Winter Conference on Medicinal and Synthetic Chemistry About the event: 25-29 January 2026, St. Anton, Austria The Alpine Winter Conference on Medicinal and Synthetic Chemistry provides participating scientists
At Taros we regularly perform contract research with an emphasis on the design and synthesis of novel building blocks, intermediates and final compounds for several applications. We pride ourselves on a 20 year track record of success in supporting diverse industries with their chemistry and innovation challenges. Our scientists specialize in organic and organometallic synthesis including polymers, from lab scale to pilot quantities. Taros operates a customer-centric and flexible business model providing our diverse clients with customized innovative discovery chemistry services:
Biotechs simply concentrate on their research and development tasks while our experienced chemists take care of all related synthetic chemistry challenges.
From new release mechanisms in band-aid material to the development of chemistry for innovative dual modes of action to help make use of new imaging techniques (PET).
Innovative display technologies require performance chemicals that allow tomorrow’s visual applications in handheld devices, car interfaces or further intelligent equipment.
Providing innovative but cost efficient early drug discovery services and technologies to our pharma customers is what drives our multidisciplinary scientists at Taros.
From literature research to pilot plant – we deliver sophisticated chemicals with full IP to our customers to help them achieve their product development goals.
Your R&D has a specific idea about how the surface should perform by modulating the coating or the curing? Get in touch with our scientists to discuss your chemistry challenge.
Great academic research often requires industrial backing and excellent synthesis capacities to bring ideas to the market – for many years we have been closing that gap.
Get in touch with us if you’d like to discuss the development of new or the improvement of existing synthetic molecules for fragrances, skin care applications or aroma molecules.
Smarter consumer goods require both improved properties and chemicals that provide an acceptable ecological footprint during their entire life cycle.
